Conhecimento dos pacientes com câncer avançado sobre seu diagnóstico e modalidade de tratamento
DOI:
https://doi.org/10.34019/2446-5739.2025.v11.46686Palabras clave:
Metástase Neoplásica, Qualidade de Vida, Cuidados Paliativos Integrativos, Terapias Complementares, Enfermagem OncológicaResumen
Objetivo: Avaliar o conhecimento do paciente com câncer avançado, sobre o seu diagnóstico e modalidade de tratamento farmacológico e não farmacológico. Método: Estudo transversal realizado em um hospital universitário do sul do Brasil, inclusos participantes com diagnóstico de câncer avançado, sendo a coleta realizada de outubro de 2022 a fevereiro de 2024. Foram coletados dados sociodemográficos, clínicos e questões relacionadas ao conhecimento do prognóstico e tratamentos. Resultados: Foram 101 participantes, com média 56,8 anos; sendo a 73,3% mulheres (p<0,05), 38,6% com câncer mama (p<0,05) e múltiplas metástases; 49,5% eram cientes do câncer avançado (p<0,05), 30,7% desconheciam o estágio da doença, 37,6% o objetivo do tratamento e 33,7% acreditavam que o tratamento era curativo; 94,1% não tiveram indicação de terapia não farmacológica por profissional de saúde (p<0,05). Conclusão: Os pacientes apresentaram limitações quanto à compreensão do estágio da doença, objetivos do tratamento e uso de terapias não farmacológicas.
ABSTRACT
Objective: To assess the knowledge of patients with advanced cancer regarding their diagnosis and pharmacological and non-pharmacological treatment modalities. Method: A cross-sectional study conducted in a university hospital in southern Brazil, including patients diagnosed with advanced cancer. Data collection took place from October 2022 to February 2024. Sociodemographic and clinical data were collected, along with questions related to knowledge of prognosis and treatments. Results: A total of 101 participants were included, with a mean age of 56.8 years; 73.3% were women (p<0.05), 38.6% had breast cancer (p<0.05), and multiple metastases; 49.5% were aware of the advanced cancer diagnosis (p<0.05), 30.7% were unaware of the disease stage, 37.6% did not understand the treatment objectives, and 33.7% believed the treatment was curative; 94.1% had not been advised on non-pharmacological therapy by a healthcare professional (p<0.05). Conclusion: Patients showed limitations in understanding the stage of the disease, treatment objectives, and the use of non-pharmacological therapies.
Descargas
Citas
Instituto Nacional do Câncer. Estimativa 2023: incidência de câncer no Brasi [Internet]. Rio de Janeiro: INCA, 2022 [citado 25 Nov 2024]. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-2023.pdf
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 [citado 25 Nov 2024];74(3):229-263. Disponível em: https://doi.org/10.3322/caac.21834
Ganesh K, Massagué J. Targeting metastatic cancer. Nat Med [Internet]. 2021 [citado 25 Nov 2024];27(1):34–44. Disponível em: https://doi.org/10.1038/s41591-020-01195-4
Hegde M, Naliyadhara N, Unnikrishnan J, Alqahtani MS, Abbas M, Girisa S, et al. Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives. Cancer Lett [Internet]. 2023 [citado 25 Nov 2024];556:216066. Disponível em: https://doi.org/10.1016/j.canlet.2023.216066
Silva LS, Lenhani BE, Tomim DH, Guimarães PRB, Kalinke LP. Quality of Life of Patients with Advanced Cancer in Palliative Therapy and in Palliative Care. Aquichan. 2019 [citado 25 Nov 2024];19(3):e1937–e1937. Disponível em: https://doi.org/10.5294/aqui.2019.19.3.7
Freire MEM, Costa SFG da, Lima RAG de, Sawada NO. Qualidade de Vida Relacionada à Saúde de Pacientes com Câncer e Cuidados Paliativos. Texto contexto-enferm [Internet]. 2018 [citado 25 Nov 2024];27(2):e5420016. Disponível em: https://doi.org/10.1590/0104-070720180005420016
Nogueira LA, Machado CAM, Marques ACB, Kalinke LP. Implications of financial toxicity in the lives of cancer patients: a reflection. Rev Gaúcha Enferm [Internet]. 2021 [citado 25 Nov 2024];42:e20200095. Disponível em: https://doi.org/10.1590/1983-1447.2021.20200095
Cancer Research UK [Internet]. Palliative treatment. 2024 [citado 25 Nov 2024]. Disponível em: https://www.cancerresearchuk.org/about-cancer/treatment/palliative
Akoo C, McMillan K. An Evolutionary Concept Analysis of Palliative Care in Oncology Care. Adv Nurs Sci. 2023 [citado 25 Nov 2024];46(2):199–209. Disponível em: https://doi.org/10.1097/ans.0000000000000444
Saraiya B, Dale W, Singer EA, Cella D. Integration of Palliative and Supportive Care Into the Management of Genitourinary Malignancies. Am Soc Clin Oncol Educ B. 2022 [citado 25 Nov 2024];(42):341–50. Disponível em: https://doi.org/10.1200/edbk_350880
Silva LS, Sousa AFD, Carvalho DHF, Kalinke LP. Non-pharmacological therapies for cancer patients in Portugal and Brazil: an experience report. Rev Esc Enferm USP [Internet]. 2023 [citado 25 Nov 2024];57:e20230091. Disponível em: https://doi.org/10.1590/1980-220X-REEUSP-2023-0091en
Plateforme universitaire Collaborative d’Evaluation des programmes de Prévention et de Soins de support (Plateforme CEPS) [Internet]. 2024 [citado 25 Nov 2024]. Disponível em: https://plateformeceps.www.univ-montp3.fr/fr/nos-services/classificationinm
van der Velden NCA, van Laarhoven HWM, Burgers SA, Hendriks LEL, de Vos FYFL, Dingemans A-MC, et al. Characteristics of patients with advanced cancer preferring not to know prognosis: a multicenter survey study. BMC Cancer [Internet]. 2022 [citado 25 Nov 2024];22(1):941. Disponível em: https://doi.org/10.1186/s12885-022-09911-8
Visentin A, Mantovani FM, Kalinke LP, Boller S, Sarquis LMM. A terapêutica paliativa em adultos com câncer: um estudo transversal. Rev Bras Enferm [Internet]. 2018 [citado 25 Nov 2024];71(2):272–9. Disponível em: http://dx.doi.org/10.1590/0034-7167-2016-0563
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007 [citado 25 Nov 2024];335(7624):806–8. Disponível em: https://doi.org/10.1016/j.jclinepi.2007.11.008
Rodríguez-Gonzalez A, Carmona-Bayonas A, Hernandez San Gil R, Cruz-Castellanos P, Antoñanzas-Basa M, Lorente-Estelles D, et al. Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer. Clin Transl Oncol [Internet]. 2023 [citado 25 Nov 2024];25(12):3492–500. Disponível em: https://doi.org/10.1007/s12094-023-03214-5
Lee EM, Jiménez-Fonseca P, Galán-Moral R, Coca-Membribes S, Fernández-Montes A, Sorribes E, et al. Toxicities and Quality of Life during Cancer Treatment in Advanced Solid Tumors. Curr Oncol. 2023 [citado 25 Nov 2024];30(10):9205–16. Disponível em: https://doi.org/10.3390/curroncol30100665
Mani K, Deng D, Lin C, Wang M, Hsu ML, Zaorsky NG. Causes of death among people living with metastatic cancer. Nat Commun. 2024 [citado 25 Nov 2024];15(1):1–9. Disponível em: https://doi.org/10.1038/s41467-024-45307-x
Paiva CE, Teixeira AC, Lourenço BM, Preto DD, de Oliveira Valentino TC, Mingardi M, et al. Anticancer Treatment Goals and Prognostic Misperceptions among Advanced Cancer Outpatients. Int J Environ Res Public Health. 2022 [citado 25 Nov 2024];19(10). Disponível em: https://doi.org/10.3390/ijerph19106272
Manalo MFC, Yang GM, Reandelar MJ, Ozdemir Van Dyk S, Malhotra C, Finkelstein EA. Cancer patients’ awareness of extent of disease: anxiety, depression, quality of life. BMJ Support Palliat Care. 2023 [citado 25 Nov 2024]. Disponível em: https://doi.org/10.1136/spcare-2022-004112
Polacek LC, Saracino RM, Walsh LE, Jutagir DR, Costas-Muniz R, Applebaum AJ, et al. How patients with advanced cancer conceptualize prognosis: A phenomenological qualitative inquiry. Palliat Med. 2023 [citado 25 Nov 2024];37(7):1006–15. Disponível em: https://doi.org/10.1177/02692163231173067
Ng S, Ozdemir S. The associations between prognostic awareness and health-related quality of life among patients with advanced cancer: A systematic review. Palliat Med. 2023 [citado 25 Nov 2024];37(6):808–23. Disponível em: https://doi.org/10.1177/02692163231165325
Bari S, Chineke I, Darwin A, Umar A, Jim H, Muzaffar J, et al. Awareness, Use and Outlook of Complementary and Alternative Medicine (CAM) Options in an Underserved, Uninsured Minority Cancer Patient Population. Integr Cancer Ther [Internet]. 2021 [citado 25 Nov 2024];20:15347354211051622. Disponível em: https://doi.org/10.1177/15347354211051622
Gowin K, Muminovic M, Zick SM, Lee RT, Lacchetti C, Mehta A. Integrative Therapies in Cancer Care: An Update on the Guidelines. Am Soc Clin Oncol Educ B [Internet]. 2024 [citado 25 Nov 2024];44(3):e431554. Disponível em: https://doi.org/10.1200/EDBK_431554
Santos ATN, Nascimento, Natali dos Santos; Alves PGJM. Efeitos de Abordagens não Farmacológicas nos Sintomas Físicos de Indivíduos com Câncer Avançado: Revisão Sistemática. Rev Bras Cancerol [Internet]. 2022 [citado 25 Nov 2024];68(2):1–14. Disponível em: https://doi.org/10.32635/2176-9745.RBC.2022v68n2.2125
Mao JJ, Pillai GG, Andrade CJ, Ligibel JA, Basu P, Cohen L, et al. Integrative oncology: Addressing the global challenges of cancer prevention and treatment. CA Cancer J Clin. 2022 [citado 25 Nov 2024];72(2):144–64. Disponível em: https://doi.org/10.3322/caac.21706
Kwong MH, Ho L, Li ASC, Nilsen P, Ho FF, Zhong CCW, et al. Integrative oncology in cancer care – implementation factors: mixed-methods systematic review. BMJ Support Palliat Care [Internet]. 2023 [citado 25 Nov 2024]. Disponível em: https://doi.org/10.1136/spcare-2022-004150
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2025 Leonel dos Santos Silva, Ana Paula Felicio de Lima, Cleo Watanabe Pisaia, Lourdes Maria Rosinski Lima Gomes, Natália Naome Oshiro, Paulo Ricardo Bittencourt Guimarães , Luciana de Alcantara Nogueira, Luciana Puchalski Kalinke
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
